PBITV3 : A robust and comprehensive tool for screening pathogenic proteomes for drug targets and prioritizing vaccine candidates

Abstract excerpt

Abstract Rise of life‐threatening superbugs, pandemics and epidemics warrants the need for cost‐effective and novel pharmacological interventions. Availability of publicly available proteomes of pathogens supports development of high‐throughput discovery platforms to prioritize potential drug‐targets and develop testable hypothesis for pharmacological screening. The pipeline builder for identification of target...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Computational Drug Discovery Methods
• Share to Tuberculosis Research and Epidemiology
• Share to vaccines and immunoinformatics approaches